| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 4,583 | 3,234 | 2,947 | 4,504 | | Cost of Revenue | 3,096 | 2,356 | 1,788 | 2,677 | | | Gross Profit | 1,488 | 878 | 1,159 | 1,827 | | | Operating Expenses | | Research Development | 584 | 683 | 636 | 841 | | Selling General and Administrative | 2,711 | 3,044 | 3,014 | 4,031 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,806) | (2,849) | (2,491) | (3,045) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 11 | 25 |
-
| 33 | | Earnings Before Interest And Taxes | (1,795) | (2,824) | (2,491) | (3,011) | | Interest Expense | 76 | 1,744 | 24 | (2) | | Income Before Tax | (1,871) | (4,567) | (2,515) | (3,009) | | Income Tax Expense | (276) | (235) | (181) | (260) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,595) | (4,333) | (2,334) | (2,749) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,595) | (4,333) | (2,334) | (2,749) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,595) | ($4,333) | ($2,334) | ($2,749) |
|
0.67% Nasdaq 0.00%
Income Statement
